Shreyas Joshi, MD
@ssjoshi.bsky.social
130 followers 61 following 4 posts
Assistant Professor in Urologic Oncology, Emory University, Winship Cancer Institute
Posts Media Videos Starter Packs
Reposted by Shreyas Joshi, MD
Reposted by Shreyas Joshi, MD
emoryuroonc.bsky.social
Congratulations to our very own @tgoodstein.bsky.social for being awarded the 2025 Society of Urologic Oncology #CGOncology #NMIBC Fellowship Grant at #AUA2025 @ssjoshi.bsky.social @drnarayan.com
Reposted by Shreyas Joshi, MD
drnarayan.com
Thanks again to Tommy Korn and everyone at Sharp Healthcare for hosting a fantastic Spatial Computing Health Care Summit - awesome to see all the amazing things people have been doing with Apple #VisionPro & to share some of what we’ve been able to do with our partners at #KarlStorz #SharpSpatial
Reposted by Shreyas Joshi, MD
valentinagrajales.bsky.social
“Grateful to be at #SWIU surrounded by incredible women—friends, colleagues, and mentees. Inspired by the exchange of ideas and learning about topics that truly empower us to lead fulfilled and successful lives. Here’s to growth, community, and innovation! 🩷 #WomenInUrology@emoryuroonc.bsky.social
Emory Urology
Reposted by Shreyas Joshi, MD
emoryuroonc.bsky.social
Interested in learning about Emory’s
#SUO fellowship?
📆 Join us for a virtual open house on Thursday, Jan 16th from 7-8 PM EST

DM or email us if you’re interested -we’ll send you a link! @ssjoshi.bsky.social @valentinagrajales.bsky.social @tgoodstein.bsky.social @winshipatemory.bsky.social
Reposted by Shreyas Joshi, MD
urogeek.bsky.social
Hello all. #urology #redsox #coys #golf #newyorkgiants
Reposted by Shreyas Joshi, MD
drnarayan.com
Proud of our first @emoryuroonc.bsky.social SUO fellow #TaylorGoodstein making a splash in RCC research at the #SUO24 Winter Meeting

@ssjoshi.bsky.social @jackiebrownmd.bsky.social
ssjoshi.bsky.social
Packed house at SUO2024 for NMIBC discussion. Our thought leader @drnarayan.com from @emoryuroonc.bsky.social @winshipatemory.bsky.social
Ongoing challenge: how do we manage high risk NMIBC? Especially those with variants?
@valentinagrajales.bsky.social
Reposted by Shreyas Joshi, MD
drnarayan.com
Interesting study…only 56% OS at 5 years strikes me as lower than I would expect; by comparison an 80% 5 year OS was observed in the ph3 nado trial for BCG unresponsive pts (76% in CIS only patients, 86% in papillary dz). Worth calling out the 53% grade 3 AE rate as well… @emoryuroonc.bsky.social
yukselurun.bsky.social
☢️💊💉Trimodality therapy offers hope for recurrent T1 bladder cancer after BCG failure!
✅ 3-year freedom from cystectomy: 88%
✅ 3-year OS: 69%
🔷monitoring is key.
#BladderCancer #Oncology
@oncoalert.bsky.social @oncbrothers.bsky.social
@achoud72.bsky.social
ssjoshi.bsky.social
Urology residents of @bsky.app , let us know if you will be in Dallas for SUO 2024 and would like to chat about the @emoryuroonc.bsky.social SUO Fellowship! @drnarayan.com @valentinagrajales.bsky.social
Reposted by Shreyas Joshi, MD
erplimackmd.bsky.social
Join the conversation on all things #bladdercancer #kidneycancer #prostatecancer and help grow the GU Oncology Starter Pack go.bsky.app/6NdMXmY
ssjoshi.bsky.social
@urocroll.bsky.social finally wearing his eagles cap without room full of groans